Havish Thatavarthi, Founder at MathMinds, shared a post on LinkedIn:
“A few millimeters in radiation planning can be the difference between cure and recurrence.
That’s the reality in Nasopharyngeal Carcinoma (NPC), a disease where precision isn’t optional. It’s everything.
This MedNews Week | OncoDaily lecture features Dr. Melvin L.K. Chua, whose work in precision oncology is helping redefine how we treat NPC.
‘Precision at the Core: Advancing Nasopharyngeal Carcinoma Care with Proton Beam Therapy’
Key takeaways:
- Proton beam therapy isn’t just a technical upgrade. It’s a clinical philosophy shift toward sparing what matters while targeting what doesn’t
- The difference between IMRT and IMPT goes beyond dosimetry. It shows up in quality of life: less xerostomia, less dysgeusia, less dysphagia
- Dr. Chua’s newly published international consensus guidelines in The Lancet Oncology represent a landmark moment for global NPC care
- The art of contouring and target delineation is just as important as the technology delivering the dose
Modern oncology isn’t just about treating more aggressively. It’s about treating more intelligently.
If you’re a student, resident, or clinician in oncology, this one is worth pressing play. You won’t regret it.”